In addition to providing high-quality, culturally competent healthcare and supportive services targeted to LGBTQ communities and people living with HIV/AIDS, Callen-Lorde also serves as a center of excellence – helping to train the future leaders in LGBT health while blazing new trails through research and other strategic partnerships. Below are our current research studies:



Leading Innovation for Transgender Women’s Health and Empowerment (LITE) is the first cohort study of transgender women and transfeminine people in the US. This project is an exciting new NIH-supported research study that will enroll 1,100 transgender women across five US cities (Boston, New York, Baltimore-Washington DC, Atlanta and Miami) beginning in early 2018.

This is a cohort study, which means we will check-in with participants approximately every 3 months for up to 2 years, with incentives given at each check-in up to $450. The study focuses on sexual health and HIV in order to learn about engagement in HIV prevention and treatment; however, we will also be collecting data on a wide range of topics in efforts to improve the health and wellness of these populations over time. This project is a partnership between Johns Hopkins Bloomberg School of Public Health, Boston Children’s Hospital, Fenway Health, Harvard University T.H. Chan School of Public Health, Callen-Lorde Community Health Center, University of Miami, Emory University and Grady Memorial Hospital, and Whitman Walker Health.

For information or to enroll, contact Sadath Ahmed, Clinical Research Supervisor: or phone the STUDY LINE 212-271-7242.



The PRIDE Study is the first large-scale, long-term health study of people who identify as lesbian, gay, bisexual, transgender, queer (LGBTQ), or another sexual or gender minority.

By participating in The PRIDE Study over time, your unique story teaches us about the health and well-being of LGBTQ people like you. Make your voice heard!